Price: FREE for members and non-members

The complexities of type 2 inflammation in uncontrolled asthma may seem like high tide. This emerging phenotype and endotype accounts for 70% of asthma cases. There are targeted therapies, but how do we use them properly?

Our free webinar Uncontrolled Asthma: the Role of Type 2 Inflammation will keep you at the helm of managing this disease.

Experts Jonathan Bernstein, MD, FACAAI and Jonathan Bayuk, DO, FACAAI will discuss asthma heterogeneity and pathobiology, the role of type 2 cytokines, phenotypes and endotypes, type 2 inflammation and comorbidities and management and biologics.
 

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.